Oxfam says 'no evidence' AMFm has saved lives; Global Fund says claims are 'untrue,' Guardian reports

NewsGuard 100/100 Score

Noting "[t]he U.K. government has contributed £70 million [$112 million] to the Affordable Medicines Facility for malaria (AMFm)," the Guardian reports, "The charity Oxfam has cast doubt on [the] international scheme that aims to boost the provision of the most effective treatment for malaria." According to the newspaper, "Oxfam says there is no evidence the program has saved the lives of the most vulnerable people" and "has criticized it as 'risky and dangerous.'" But "[t]he body behind the AMFm says an independent study shows it has improved access and reduced drug prices," and "[t]he Global Fund said Oxfam's claims were 'simply untrue,'" the Guardian writes, adding, "A DfID spokesman said: ... 'Studies have shown that quality drugs have got through to remote areas -- and that more vulnerable groups, including children under five in rural areas and from the poorest backgrounds, are now being reached'" (Dreaper, 10/24).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pioneering study launched to examine how the immune system responds to repeated malaria infections